Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.86
-0.06-0.67%
Last update: Oct 9, 9:30 AM
$8.86
-0.06-0.67%
Sagimet Biosciences Inc (SGMT) Stock Price, Quote, News & History
SGMTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Sagimet Biosciences (NASDAQ:SGMT) through any online brokerage.
Other companies in Sagimet Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Sagimet Biosciences has a consensus price target of $25.23.
The stock price for Sagimet Biosciences (NASDAQ: SGMT) is $8.86 last updated October 9, 2026 at 9:30 AM EDT.
There are no upcoming dividends for Sagimet Biosciences.
Sagimet Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Sagimet Biosciences.
Sagimet Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
